This report contains market size and forecasts of Viibryd (Vilazodone) in global, including the following market information:
Global Viibryd (Vilazodone) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Viibryd (Vilazodone) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Viibryd (Vilazodone) companies in 2021 (%)
The global Viibryd (Vilazodone) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
10 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Viibryd (Vilazodone) include Allergan plc (AbbVie Inc.), Actavis Generics (Teva) and Clinical Data, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Viibryd (Vilazodone) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viibryd (Vilazodone) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Viibryd (Vilazodone) Market Segment Percentages, by Type, 2021 (%)
10 mg
20 mg
40 mg
Global Viibryd (Vilazodone) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Viibryd (Vilazodone) Market Segment Percentages, by Application, 2021 (%)
Major Depression
Anxiety
Others
Global Viibryd (Vilazodone) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Viibryd (Vilazodone) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viibryd (Vilazodone) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Viibryd (Vilazodone) revenues share in global market, 2021 (%)
Key companies Viibryd (Vilazodone) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Viibryd (Vilazodone) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan plc (AbbVie Inc.)
Actavis Generics (Teva)
Clinical Data, Inc.